Skip to content
Back to Investors
E

Exor

Other

Exor Ventures is the early-stage investment arm of Exor N.V. and was founded in 2018 in New York. We invest in early-stage companies from Seed to Series B, across healthcare, mobility and SaaS/AI.

Portfolio

6

companies

By category

  • EventTech£51.2M
  • AI/ML£14.5M
  • HRTech£13.1M
  • HealthTech£6.3M
  • BioTech£6.3M

By location

  • London£91.4M

Portfolio companies

DICE

DICE

DICE provides an independent mobile ticketing platform for live music and cultural events.

Desia

Desia

Desia provides artificial intelligence applications for productivity, automation, and analytics in financial services.

H

Humaans

Humaans provides modular human resource software for modern workplaces.

J

Jigsaw

Jigsaw provides a visual platform for managing corporate structures using data and artificial intelligence.

S

SAVA

SAVA develops pain-free real-time microsensors for health monitoring.

ST

SAVA Technologies

SAVA Technologies develops wearable biosensors for continuous health monitoring.


Team

Noam Ohana

Noam Ohana

Noam brings investment and venture experience, having previously led Exor Ventures and served as managing director at Exor. He currently serves as managing partner at Ora Global and sits on the board of Via.

LinkedIn
ML

Michael Lavner

Ileana Pirozzi

Ileana Pirozzi

Ileana brings investment experience from roles at General Catalyst and Reaction. She has also held strategy and advisory positions across various organisations, including OpenAI and Multiply Labs.


Recent investments

Pre-Seed
£2.5M

Dig Ventures led the pre-seed financing round to support product development and international growth.

"I recall regularly sifting through data and information until the early hours during my time at Goldman Sachs in order to make fully informed decisions and strategies. With Desia the whole process would have been more efficient and successful. I wish it was available back then."
— Raffaele Terrone, CEO
Seed
$8.0M

The London startup will use the capital to expand its team, develop next-generation products, and demonstrate clinical performance.

"This could be the defining product in personal health monitoring in the coming decade, and an essential tool for patients and clinicians in diagnosing and treating many chronic diseases as well. Renato and Rafael have a compelling user-centric vision to revolutionise chronic disease management and preventative care, and the credibility and knowledge to execute in this vital area."
— James Wise, Partner
Seed
£6.3M

Balderton Capital and Exor Ventures have led a seed round to help finance clinical trials and expand manufacturing capabilities.

"At SAVA we are tackling preventable illness by building a new operating system for health monitoring. Our microsensor will revolutionise healthcare by making world-leading monitoring technology available to all. With this capital, we can accelerate our goal of creating a new paradigm for healthcare – preventative, personalised and painless."
— Renato Circi, Co-founder
Series A
£12.0M

The Series A round was led by Exor Ventures with backing from various angel investors to support product development and international growth.

"We’ve dedicated ourselves to building products that white-collar professionals deeply value for corporate structuring. Up next, we’re going to double down on generative AI and collaboration features. We also plan to expand our multi-product line focused on visualising complex transactions into an end-to-end platform to manage corporate structures and governance."
— Stephen Scanlan, Co-founder
£51.2M

The investment was led by MUSIC and will fund international expansion alongside new ticketing features.

"The live music industry is adopting DICE faster than ever and proves our thesis that if you treat fans well, they buy more tickets, and go out more often. We’re investing heavily in building even more technology and this year alone we released over 60 new features for fans, venues and artists. I’m excited that Matt (Pincus) has joined the Board and we’re more focused than ever on our mission to get fans out more."
— Phil Hutcheon, CEO and Founder